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sRNA acts as an adaptor in the transfer of amino acids into protein. 1-5 Since an
organism may contain more than one variety of sRNA for a given amino acid,
different coding specificities of the various adaptors would provide a mechanism for
degeneracy in the code. In E. coli sRNA, several leucine-acceptors have been
shown to respond differently to various synthetic polynucleotides.5' 6 The experi-
ments reported here were undertaken to determine whether the separate leucyl-
sRNA's actually contribute leucine to different sites in natural polypeptide chains.
Evidence that they do is presented in this paper.
Materials and Methods.-Separation of leucine acceptors: sRNA from E. coli strain B prepared
by phenol extraction was obtained from General Biochemicals, Chagrin Falls, Ohio. Counter-
current distributions were performed with a 400-tube apparatus according to Holley et al. The
solvent system was made by dissolving 550 gm K2HPO4 and 850 gm NaH2PO4 H2O in 4 liters of
deionized water. To this, 300 ml formamide and 1535 ml isopropanol were added. Four hundred
transfers were performed at 280C. The 400 fractions obtained were combined into 80 sets of 5 tubes
each. Assays of acceptor activity were done as previously described,6 except that a partly purified
E. coli leucine-activating enzyme preparations was used instead of a crude E. coli extract. After
incubating the fractions, the sRNA was precipitated with ice-cold 5% trichloroacetic acid (TCA).
The precipitate was collected and washed with ice-cold 5% TCA on a membrane filter (Millipore).
The filters were glued to planchets, dried, and counted.
Preparation of leucyl-sRNA: Attachment of labeled leucine to sRNA and isolation of C'4-
leucine- and H3-leucine-bound sRNA were performed as previously described5' 6 except that a
partly purified E. coli leucine-activating enzyme preparations was used. Uniformly labeled C14-
leucine, specific activity 240 ,4c/puM and 4,5 H3-leucine, specific activity 5000 lic/IAM were products
of the New England Nuclear Corp. Further details are given in the legends to the figures.
Preparation of reticulocyte ribosomes: Ribosomes from rabbit reticulocytes can be used to syn-
thesize hemoglobin in vitro. They were prepared by the method described by Schweet et al.9 ex-
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cept that sucrose was omitted and Tris-HCl replaced the bicarbonate buffer. The temperature
was 40C unless otherwise stated. The following stock solutions were used:
Tris-HCl -mercapto-
Solution pH 7.6 MgC12 KC1 ethanol
A 0.003 M 0.003 M - 0.007 M
B 0.003 M - 0.15 M 0.007M
C 0.003 M 0.001 M 0.05 M 0.007 M
The packed reticulocytes were lysed by rapid suspension in 3 vol of solution A. After 5 min, 1
vol of solution B was added. Cell membranes were removed by centrifugation at 10,000 X g for
10 min. Ribosomes were obtained from the supernatant by centrifugation at 100,000 g for 120
min and suspended gently in solution C, at a concentration of about 20 mg RNA per ml, with
the aid of a Potter-Elvehjem homogenizer.
Transfer of leucine into hemoglobin: The transfer mixture of von Ehrenstein and Lipmann'0
was modified to contain ATP and a low concentration of magnesium. The reaction was performed
in 10 ml and contained (in jumoles unless otherwise noted): Tris-HCl, pH 7.6, 1000; KCl, 250;
MgCl2, 3; GSH, 80; GTP, 5; ATP, 10; PEP, 100; PEP kinase, 400 ug; C'2-leucine, 20; 19
C'2-amino acids (leucine omitted), 2 each; H3-leucine attached to peak I sRNA, 1,600,000 cpm,
1200 ,ug sRNA; C'4-leucine attached to peak IIB sRNA, 142,000 cpm, 300 ,ug sRNA; reticulocyte
ribosomes, 1500 O.D.260 units. After incubation for 30 min at 37°C, the mixture was chilled, and
400 mg of hemoglobin from rabbit reticulocytes added as carrier. The volume was adjusted
to 13 ml with solution C, and ribosomes were removed by centrifugation at 100,000 X g for 2 hr.
Preparative phenolation of hemoglobin: To the supernatant obtained from the previous step, an
equal volume of water-saturated phenol was added, and the mixture was agitated on a vortex
mixer for 1 min at room temperature. After centrifugation at 10,000 g for 5 min, the mixture
separated into a colorless upper aqueous phase containing the sRNA and a clear dark brown lower
phenol phase containing the carrier- and in vitro-synthesized hemoglobin. The hemoglobin in
the phenol phase, including a small amount of insoluble residue at the interface, was converted to
globin by adding it dropwise at room temperature with vigorous stirring, to 10 vol of acetone con-
taining 1 ml concentrated HCl per liter.11 The flocculent tan-colored precipitate was collected
by centrifugation at 2000 X g for 5 min, washed with acetone, and dissolved in water at a final
concentration of 10 mg per ml yielding a clear, slightly brownish solution of globin. Formic acid
and pyridine were added to final concentrations of 0.2 M and 0.02 M, respectively.
Chain separation: The globin was separated into its constituent a- and a-chains according to
the method of Dintzis.12 The sample containing approximately 400 mg globin was applied to a
15 X 2.5-cm carboxymethyl-cellulose column (8 gm dry weight, Serva Entwikelungslabor, Heidel-
berg, Germany, exchange capacity 0.71 meq/gm), and eluted with a linear gradient (500 ml 0.2 M
formic acid plus 0.02 M pyridine in the mixing chamber; 500 ml 2.0 M formic acid plus 0.2 M
pyridine in the reservoir).
Digestion of a-chain and $-chain with trypsin: The pooled a-chain fractions and pooled 0-chain
fractions were taken to near dryness on a rotary evaporator, and dissolved in 20 ml water. The
pH was adjusted to 9.0 with 0.2 N NaOH. Two mg trypsin was added and the digestion mixture
maintained at pH 9.0 for 3 hr, by addition of 0.1 N NaOH. The pH was then reduced to 6.4 with
1 N acetic acid. The digest was frozen and thawed, and the insoluble "core" removed by centri-
fugation at 10,000 g for 10 min.
Ion exchange chromatography of peptides: The supernatant containing the soluble peptides was
fractionated according to the method of Jones.13 It was evaporated to near dryness, dissolved
in 2% formic acid, and applied to a 20 X 0.9-cm column of Dowex 50 X 8 (Type 15A resin, Beck-
man Instruments, Inc., Palo Alto, Calif.). The peptides were eluted with a concave gradient
produced with the aid of a 7-chamber varigrad apparatus. Chambers 1, 2, 3, and 4 each contained
200 ml pH 3.1 buffer ( 1114 ml glacial acetic acid, 64.5 ml pyridine diluted to 41 with distilled water),
while chambers 5, 6, and 7 each contained 200 ml pH 5.0 buffer (573 ml glacial acetic acid, 645
ml pyridine diluted to 4 1 with distilled water).
Aliquots were assayed with ninhydrin by the method of Moore and Stein.14 Aliquots for liquid
scintillation counting were dried down at 60°C in 20-ml glass counting vials and the samples dis-
solved in 0.2 ml 0.1 N HCl. Fifteen ml of scintillator solution (10 gm 2,5-diphenyloxazole (PPO);
0.5 gm 1,4-bis-2-(5-phenyloxazolyl)-benzene (POPOP), 500 ml ethanol, and 1500 ml toluene) was
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added, and the H3 and C14 content determined with a Packard liquid scintillation counter. The
peak fractions were pooled, lyophilized, and further resolved by electrophoresis on Whatman 3MM
filter paper at 50 v/cm for 90 min using pyridinium acetate buffer pH 6.4 (100 ml pyridine, 4 ml
glacial acetic acid, 900 ml water). The purified peptides were located by staining guide strips
with ninhydrin (0.2% ninhydrin in acetone).
The amino acid compositions of the purified peptides were determined following acid hydroly-
sis by column chromatography using a Technicon amino acid analyzer. The compositions of the a-
chain peptides were compared with those reported by Diamond and Braunitzer"5 and the peptides
numbered according to their convention.
Results.-Separation of leucine-acceptor sRNA's: Figure 1 shows the resolution
of leucine-acceptor sRNA's into five components by countercurrent distribution.
Peaks IA, IB, and IC represent further resolution of the peak I previously repor-
ted,5 6 while peaks IIA and IIB correspond to those found earlier, representing sub-
divisions of the one originally designated as peak jI.5 6 Five components have also
been found by Apgar and Holley."6
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FIG. 1.-Resolution of 5 leucine acceptors by countercurrent distribution of E. coli sRNA. The
polynucleotide most active in stimulating leucine transfer from each peak is indicated in paren-
theses.
In earlier experiments with synthetic polynucleotides5 I peak I responded prefer-
entially to poly UC, peak IIA to poly U, and peak IIB to poly UG. It has since
been shown that the high magnesium concentrations employed can increase am-
biguity in coding."7 Therefore, the various leucine sRNA's were retested in the
E. coli system at a low magnesium concentration (0.005 M). The differences
between various peaks confirmed those reported previously.5' 6 Peaks IA, IB, and
IC all responded optimally to poly UC and were therefore pooled in preparing sub-
strates for the hemoglobin transfer and referred to collectively as "peak I."
Distribution of leucine transferred into hemoglobin peptides: A double label experi-
ment was performed in order to compare the specificity of transfer of leucine from
peak I and peak IIB sRNA's. H3-leucine attached to peak I-sRNA, and C14-
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FIG. 2.-Separation of tryptic peptides of the a-chain of rabbit hemoglobin labeled by simul-
taneous transfer from H3-leucine-charged peak I sRNA and C14-leucine-charged peak IIB sRNA.
(a) Ninhydrin assay of fractions from Dowex 50 column. (b) H3 counts in column fractions.
(c) C'4 counts in column fractions. (d) Tubes of special interest, 81-85 (see text), were pooled
and further fractionated by paper electrophoresis. A guide strip was stained with ninhydrin to
locate the peptides, and its photograph is shown. (Distance from the origin to peptide aT9 is
17 cm.) Corresponding parts of the remaining paper strip were eluted with 1 N acetic acid. After
evaporation of the acetic acid, samples were dissolved in 0.2 ml 0.1 N HCl and assayed for H3-
and C14 content using liquid scintillation counting. Radioactivity contained in equivalent ali-
quots is tabulated.
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leucine attached to peak 1IB-sRNA were mixed and transferred simultaneously into
hemoglobin as described in Materials and Methods. Rabbit reticulocyte hemoglobin
was added as a carrier, the soluble hemoglobin was purified by phenol extraction,
and the a- and fl-chains were separated, digested with trypsin, and the peptides
fractionated by ion-exchange chromatography. Each fraction was assayed with
ninhydrin (indicating the carrier peptides), and the radioactivity due to transferred
H3 and C14 was determined by scintillation counting.
The results for the a-chain are shown in Figure 2. At the top is the ninhydrin
profile. The peaks were collected and further purified by electrophoresis. Follow-
ing hydrolysis, their amino acid compositions were determined (see Materials and
Methods). The peptides of interest here are those containing leucine, having their
peaks at tubes 3, 15, 48, 70, 80, and 120. They could be correlated with the pep-
tides reported by Diamond and Braunitzer,"5 with the exception of the peak at tube
3. The others correspond, respectively, to their peptides aT5 plus aT1 (un-
resolved), the ditryptide aT1 + 2, peptide aT10, peptide aT9, and peptide aT11.
Figure 2b shows the distribution of H3-leucine transferred from peak I leucyl-
sRNA. Note that six peaks (at tubes 3, 15, 48, 70, 80, and 120) received label.
The heights of the peaks are not proportional to the number of leucine residues they
contain, due to nonuniform labeling along hemoglobin chains synthesized in a cell-
free system.22
In striking contrast, the C'4-leucine attached to peak IIB-sRNA appears almost
entirely in a single peak, as shown in Figure 2c. The material in this peak (tubes
81-85) was studied in further detail. Paper electrophoresis resolved two strong
ninhydrin bands and two faint ones, as shown in Figure 2d. The radioactivity in
the two strong bands is tabulated in the figure. The fastest band received only
H3 label. Its amino acid composition corresponded to peptide aT9, containing one
leucine residue. Analysis showed that the radioactivity was all in the form of
leucine. The peptide in the next band, designated "'C14-peptide," received its
label from the C14-leucine attached to sRNA peak IIB. Analysis of the hydro-
lyzed peptide showed that the radioactivity was present solely as leucine.
TABLE 1 The amino acid composition of
AMINO ACID COMPOSITION OF THE C'4-PEPTIDE the C14 peptide, given in Table 1,
COMPARED WITH PEPTIDE aT6 does not correspond to any of the
Asp, AspNH2 C14peptide aT6 peptides previously described.15-'8
Glu, GluNH2 2 2 There is a close resemblance, how-
GPl 1 1 ever, between this peptide and aT6,
Ileu 1 1 shown for comparison. (In the
THiysr 1 2 column fractionation of Figure 2a,
Lys 1 1 peptide aT6 emerged in tubes 86-90,
Val o o immediately following the C'4-pep-
Met 0 0 tide.)
LAeg o The amount of C'4-peptide is not
Phe 2 3 accurately known; its ninhydrin
Thr 1 2 color corresponds to about one fifth
Ser 2 1 of that of aT6. Whether or not the
Total 16 16 C4-peptide belongs to a minor hemo-
Amino acids showing differences are underlined. Try and globin component has not yet been
Cys were not determined.
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established. It should be recalled that this peptide is present in the carrier hemo-
globin derived from intact reticulocytes, and fractionated together with hemoglobin
through phenol extraction and with the a-chain during its separation from the 4-
chain. Ion-exchange chromatography of rabbit reticulocyte hemoglobin on car-
boxymethyl cellulose,10 and on IRC-50,19 does indeed reveal the presence of at least
two components. We have found that electrophoresis on polyacrylamide gel also
reveals two bands. However, further investigation is needed to see whether the
C'4-peptide is associated with a separable hemoglobin type.
The two faint bands in Figure 2d each contained both arginine and lysine in about
equal amounts and therefore do not represent pure tryptic peptides. They also
contained small amounts of radioactivity (each contained 50 cpm H3 and 10 cpm
C14). Characterization of these bands must await further purification.
The peptides of the j3-chain were examined in a manner similar to that described
in Figure 2. While several peaks contained H3 transferred from leucyl-sRNA peak
I, no C14 could be detected in any of the solublefp-chain peptides. They have not
been investigated further.
Discussion.-If two sRNA's correspond to different codons, they should transfer
amino acids into different positions in polypeptide chains. This was indeed found
to be the case for the two leucine sRNA's examined.
Sueoka and Yamane20 showed that, under certain conditions, leucine can be
shifted from one sRNA to another. This transacylation is mediated by AMP and
a leucine-activating enzyme that can attach leucine to both sRNA's. To minimize
any such effect in our experiments, the reaction mixture contained a large amount
of free C'2-leucine and ATP in order to keep the rabbit sRNA as fully charged as
possible with C12-leucine and the leucine-activating enzyme saturated with C12-
leucyl-AMP. Manifestly, the transacylation effect could not have played a sig-
nificant role, or both H3- and C14 label would have appeared in all the peptides.
These experiments employed a mixed system, using sRNA from E. coli to syn-
thesize rabbit hemoglobin. Although it has not yet been specifically demonstrated
that the rabbit has an sRNA with coding specificity corresponding to peak IIB of
E. coli, this does seem likely from the fact that leucine incorporation responds to
poly UG in a rat liver system.2' Heterogeneity has been observed for leucine-
acceptor activity in rabbit liver sRNA fractionated by countercurrent distribution
(von Ehrenstein, G., and D. Dais, unpublished).
The relation of the C'4-peptide to the main hemoglobin component remains to be
clarified, but that is of secondary importance to the question under examination,
since the peptide is, in any case, one among those synthesized in the cell-free system.
Although the incorporated radioactivity is in the form of leucine, it has not yet been
shown that it actually occupies a normal leucine position. The coincidence of the
radioactivity and the leucine-containing peptide synthesized in vivo and visible with
ninhydrin is, of course, consistent with this supposition. In any case, the clear-cut
transfer of leucine from two separable sRNA's into different polypeptide positions
leads to the apparently inescapable conclusion that leucine has at least two different
kinds of coding specificity in the synthesis of natural polypeptides.
Summary.-Different leucine sRNA's in E. coli are separable by countercurrent
distribution. When these sRNA's are used as donors of labeled leucine during the
synthesis of rabbit hemoglobin, in vitro, they distribute leucine differently into
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various peptides of the a-chain. One of the sRNA's introduces leucine only into a
single position. The results indicate that there are at least two distinct codons for
leucine in the amino acid code.
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